Musculoskeletal indications


Musculoskeletal indications:

Today, PRP has become one of the mainstays of treating joint and ligament injuries. Treatment of osteoarthritis of the knee in many other cases does not require surgery. Minor ruptures of ligaments and muscles give amazing answers to this treatment. Of course, by accurately determining the indications, those who really need surgery should use the surgical method, which PRP can also help to accelerate recovery.
In studies on knee pain, comparisons between PRP and Hyalgan gels have shown better PRP results and longer lasting effects. It was similar, but over time and in the sixth month, the clinical results and patient satisfaction were staggering. Compared to PRP and corticosteroids in patients with chronic elbow pain, there is a considerable preference in PRP treatment that if you are looking for a difference in PRP treatment, you should follow the results in the long run (one to two years). Although this is not a competitor to surgery, in cases where the physician decides between corticosteroids, hyaline, and PRP, existing scientific reports (especially the American Academy of Orthopedic Surgeons) are more likely to use PRP


Enrichment index:

 For optimal PRP, the platelet concentration should be higher than the baseline value, but this direct relationship with the effective dose concentration for injectable cases has been defined as 4-7 times more than baseline count. For orthopedic cases, this dose is about 5±1 times defined.

Injection intervals:

Most studies are done at one-month intervals of this injection, but this interval should not be less than 3 weeks or more than 6 weeks, however, in some studies, these injections have been performed at 2-week intervals. after the injection protocol and achieving the desired clinical results (discussed below), annual reminder doses should not be forgotten.

Expected Results:

In orthopedic applications, especially severe osteoarthritis (DJD) and cases with severe knee deviation - genovarum and genovalgus - more than 20) and in cases of excessive weight gain (BMA˃30), patients do not respond well.

However, it is preferable in less injuries than similar common treatments such as glycosaminoglycans consumption, corticosteroid injection, Hyalgan gel, etc. In these patients with an age range of less than 65 years and preferably under 60 years, expecting an increase in quality of life, Reduction of pain, etc. for one year after the protocol. In other orthopedic applications, including sports injuries, traumas, tendonitis, etc., there are similar results.

About us

  • Rooyagen brand (ROOYA GEN) owned by Aria Mabna TashKhis -Knowledge based -Company, was born in 2010. Rooyagen, while entering the field of medical device production, became the first platelet processing and concentrating (PRP) kit in Iran after obtaining the relevant licenses. The first product in the Rooyagen PRP kit was for musculoskeletal use.

  • From the beginning of 2013, Rooyagen was able to launch another product in the field of skin rejuvenation and hair loss treatment. One of the honors of the Rooyagen brand is active participation in scientific and academic forums. The products of this brand have been cited in several (more than 50) scientific articles and have received over 1000 referral citation from scientific studies.

  • Following the path of research and development in 2016, another product of Rooyagen was produced for the treatment of chronic wounds. This kit was produced as a platelet gel with high durability and Sustain release technology and brought brilliant results. Accompaniment of professors of Tehran University of Medical Sciences - Shariati Hospital was published and is now available in clinics for the treatment of diabetic wounds and other chronic wounds

  • Simultaneously with achieving promising results for the treatment of infertility worldwide, Rooyagen product for infertility uses such as recurrent miscarriage and thin endometrium, has successfully passed its research and development stages and with the cooperation of professors of Taleghani Hospital- Beheshti University of Medical Sciences It has been clinically proven and its results have been published in authoritative ISI articles. Fortunately, today most infertility centers in the country are using this product to help infertile couples. we are proud continuing this path with your support and enthusiasm for new services to patients in need ...

  • Be Part
    Of Our

Unit 1, No.11,setayesh, satarkhanSt., Tehran.

+98 66512800